Guardion Health Sciences, Inc.
GHSI
OTC PK
| Weiss Ratings | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.42 | |||
| Price History | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $18.00 | |||
| 52-Week Low Price | $3.04 | |||
| 52-Week Low Price (Date) | Oct 01, 2024 | |||
| 52-Week High Price (Date) | Aug 23, 2024 | |||
| Valuation | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -10.38M | |||
| Price/Earnings (TTM) | 0.66 | |||
| Earnings Per Share (TTM) | 4.96 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.66 | |||
| Price/Book (Q) | 0.31 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.28M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 873 5141 | |||
| Address | 2925 Richmond Avenue Houston, TX 77098 | |||
| Website | www.guardionhealth.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -65.82% | |||
| Profit Margin | 99.18% | |||
| Management Effectiveness | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -18.38% | |||
| Return on Equity | -- | |||
| Income Statement | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.09M | |||
| Total Revenue (TTM) | 6.43M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 2.88M | |||
| EBITDA (TTM) | -4.21M | |||
| EBIT (TTM) | -4.23M | |||
| Net Income (TTM) | 6.37M | |||
| Net Income Avl. to Common (TTM) | 6.37M | |||
| Total Revenue Growth (Q YOY) | -8.42% | |||
| Earnings Growth (Q YOY) | -34.98% | |||
| EPS Diluted (TTM) | 4.96 | |||
| EPS Diluted Growth (Q YOY) | 965.89% | |||
| Balance Sheet | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.82M | |||
| Cash Per Share (Q) | $11.54 | |||
| Total Current Assets (Q) | 15.29M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 13.75M | |||
| Current Ratio (Q) | 16.671 | |||
| Book Value Per Share (Q) | $10.71 | |||
| Total Assets (Q) | 15.30M | |||
| Total Current Liabilities (Q) | 917.30K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 1.55M | |||
| Total Common Equity (Q) | 13.75M | |||
| Cash Flow | GHSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 19.90K | |||
| Cash from Financing (TTM) | 57.90K | |||
| Net Change in Cash (TTM) | -2.76M | |||
| Levered Free Cash Flow (TTM) | -2.17M | |||
| Cash from Operations (TTM) | -2.84M | |||
